Loading company…
ID 402234710 · FY 2023–2024 · 2 years
Subsidiary of შეზღუდული პასუხისგებლობის საზოგადოება უჯრედული თერაპიის ინსტიტუტი (100.0%)
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Total Revenue | 5,734 | 9,456 | +64.9% |
| Total COGS | -4,586 | -7,714 | +68.2% |
| Gross Profit | 1,148 | 1,742 | +51.7% |
| Gross Margin | 20.0% | 18.4% | |
| Total Operating Expenses | -814 | -1,676 | +105.8% |
| EBITDA | 334 | 66 | -80.1% |
| EBITDA Margin | 5.8% | 0.7% | |
| Total D&A | -3 | -6 | +154.9% |
| EBIT / Operating Income | 331 | 60 | -81.9% |
| Total Other Income | 43 | -70 | nmf |
| Profit Before Tax | 374 | -10 | nmf |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | 374 | -14 | nmf |
| Net Margin | 6.5% | -0.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).